Protein A Resins Market By 2023 to 2033: How Innovation is Shaping the Industry

 A recent study by Future Market Insights (FMI) has highlighted an impressive trajectory for the global protein A resins market, projecting a substantial expansion over the next decade. Valued at USD 677.84 million in 2023, the market is set to nearly double, reaching approximately USD 1,477.01 million by 2033. This growth is driven by a robust compound annual growth rate (CAGR) of 8.1%.

Protein A resins are critical components in the purification processes essential for the production of monoclonal antibodies. These antibodies are increasingly vital in therapeutic treatments and diagnostics, reflecting the sector's rapid growth. The rising prevalence of chronic diseases, the flourishing biopharmaceutical industry, and ongoing advancements in clinical research methodologies are significantly boosting the demand for more effective biologics.

Get Access to Sample Report Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-1720

"The global protein A resins market is poised for substantial growth in the coming years," stated Future Market Insights. "This growth is driven by the escalating demand for monoclonal antibodies in therapeutic applications, coupled with advancements in biopharmaceutical production techniques."

The study underscores that North America currently holds a significant share in the protein A resins market, owing to a robust presence of biopharmaceutical companies and substantial investments in healthcare research and development. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period, supported by increasing healthcare expenditures and expanding biopharmaceutical manufacturing capabilities in countries like China and India.


Factors Contributing to the Rise of CMOs in mAb Production:

  • Limited In-House Capabilities: Many biotechnology companies lack the internal infrastructure and expertise required for mAb production.
  • Supply Chain Complexity: Managing the complex supply chain associated with mAb manufacturing can be challenging.
  • High Financial Investment: Establishing high-containment biologic facilities requires significant financial resources, posing a risk for individual companies.

Therefore, the outsourcing of mAb development and manufacturing to CMOs is expected to create a substantial demand for protein A resins, further propelling market growth.

This highlights the projected growth of the protein A resins market, driven primarily by the increasing demand for monoclonal antibody production and the crucial role played by Contract Manufacturing Organizations.

Top Highlights from the FMI’s Analysis of the Protein A Resins Market: 

  • The United States protein A resins industry is expected to acquire more than 93.5% value share of the North America market.
  • Within Europe, the United Kingdom protein A resins industry is expected to take 24.1% of the pie in 2033.
  • The China market is anticipated to enlarge at a CAGR of 9.8% over the upcoming years.
  • High demand for natural protein A resin is expected to yield a large market share in 2023.
  • Under the matrix category, the agarose-composed matrix of protein A resins is expected to record 85.8% of the market share in 2023.
  • The antibody purification segment is projected to gain 74.8% of the global market.
  • The biopharmaceutical manufacturers segment is expected to emerge as the chief end user of the market, gaining as high as 79.2% of the market in 2023.

Key Players in the Market are:

  • GE Healthcare
  • Thermo Fisher Scientific
  • Kaneka Corporation,
  • JNC Corporation
  • Purolite Life Sciences
  • Bio-Rad Laboratories, Inc.
  • JSR Corporation (JSR Life Sciences LLC)
  • Repligen
  • Tosoh Bioscience, Merck Group (Merck Millipore)
  • Novasep Holdings SAS, Agilent Technologies, Inc.
  • GenScript, Abcam PLC (Expedeon Ltd.)
  • Avantor Inc.
  • Takara Bio, PerkinElmer, Inc.
  • Suzhou Nanomicro Technology Co., Ltd

Protein A Resins Market by Category:

Product:

  • Natural Protein A Resin
  • Recombinant Protein A Resin

Matrix:

  • Agarose-based Matrix
  • Glass or Silica-based Matrix
  • Organic Polymer-based Matrix

Application:

  • Immunoprecipitation
  • Antibody Purification

End User:

  • Biopharmaceutical Manufacturers
  • Clinical Research Laboratories
  • Academic Institutes

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more